Ambrosia Bio ltd. is a biotech company developing an enzyme-based technological platform capable of converting everyday sugars into low- to no-calorie rare sugars (e.g., allulose, and others) and dietary fibers (scFOS) in a cost-effective manner. Ambrosia bio's business model is based on revamping sugar refineries into specialty ingredient production sites.
Ziv Zwighaft, PhD, MBA, founder and CEO
Avraham Laban, PhD, CTO
Amir Barzilay, Chairman
Yoav Herschkovitz, PhD, IP & Regulation Affairs
Stanislas Baudouin, VP engineering